Title:
WT1 HELPER PEPTIDE, AND COMBINATION OF SAID PEPTIDE AND CANCER ANTIGEN PEPTIDE CONJUGATE
Document Type and Number:
WIPO Patent Application WO/2018/101309
Kind Code:
A1
Abstract:
The present application relates to a WT1 helper peptide comprising an amino acid sequence of 9-30 residues including the amino acid sequence: KLSHL, and to the combination of said peptide and a cancer antigen peptide conjugate.
More Like This:
Inventors:
BAN HITOSHI (JP)
GOTO MASASHI (JP)
TAKANASHI YOSUKE (JP)
GOTO MASASHI (JP)
TAKANASHI YOSUKE (JP)
Application Number:
PCT/JP2017/042760
Publication Date:
June 07, 2018
Filing Date:
November 29, 2017
Export Citation:
Assignee:
SUMITOMO DAINIPPON PHARMA CO LTD (JP)
INT INST CANCER IMMUNOLOGY INC (JP)
INT INST CANCER IMMUNOLOGY INC (JP)
International Classes:
C07K19/00; A61K39/00; A61P35/00; A61P35/02; C07K7/08; C07K14/00; C07K14/47
Domestic Patent References:
| WO2014157692A1 | 2014-10-02 | |||
| WO2016186177A1 | 2016-11-24 | |||
| WO2010123065A1 | 2010-10-28 | |||
| WO2007063903A1 | 2007-06-07 | |||
| WO2000006602A1 | 2000-02-10 | |||
| WO2002079253A1 | 2002-10-10 | |||
| WO2014157692A1 | 2014-10-02 | |||
| WO2005045027A1 | 2005-05-19 | |||
| WO2007047764A2 | 2007-04-26 | |||
| WO2003106682A1 | 2003-12-24 | |||
| WO2009072610A1 | 2009-06-11 | |||
| WO2002079253A1 | 2002-10-10 | |||
| WO2004026897A1 | 2004-04-01 | |||
| WO2003106682A1 | 2003-12-24 | |||
| WO2002047474A1 | 2002-06-20 | |||
| WO2006078059A1 | 2006-07-27 | |||
| WO2000006602A1 | 2000-02-10 | |||
| WO2002079253A1 | 2002-10-10 | |||
| WO2004063903A2 | 2004-07-29 | |||
| WO2007063903A1 | 2007-06-07 | |||
| WO2010123065A1 | 2010-10-28 | |||
| WO2005053618A2 | 2005-06-16 | |||
| WO2007120673A2 | 2007-10-25 | |||
| WO2010037395A2 | 2010-04-08 | |||
| WO2000018795A2 | 2000-04-06 | |||
| WO2002028414A1 | 2002-04-11 | |||
| WO2003037060A2 | 2003-05-08 | |||
| WO2004100870A2 | 2004-11-25 |
Foreign References:
| JP2016233042A | 2016-11-30 | |||
| US2868691A | 1959-01-13 | |||
| US3095355A | 1963-06-25 |
Other References:
UEDA, N. ET AL.: "BCR-ABL-specific CD 4+ T-helper cells promote the priming of antigen-specific cytotoxic T cells via dendritic cells", CELLULAR AND MOLECULAR IMMUNOLOGY, vol. 13, May 2016 (2016-05-01), pages 1 - 12, XP055490144
CLIN CANCER RES, vol. 15, no. 17, 2009, pages 5323 - 37
CANCER RES, vol. 62, no. 22, 2002, pages 6438 - 6441
J IMMUNOL IMMUNOTHER, vol. 24, no. 3, 2001, pages 195 - 204
FRONT IMMUNOL, vol. 4, no. 172, 2013, pages 1 - 9
J IMMUNOL, vol. 166, no. 11, 2001, pages 6720 - 6727
J IMMUNOL, vol. 169, no. 2, 2002, pages 739 - 749
IMMUNITY, vol. 7, no. 3, 1997, pages 387 - 399
J IMMUNOL, vol. 176, no. 5, 2006, pages 2958 - 2968
PROC. NATL. ACAD. SCI. USA, vol. 90, no. 4, 1993, pages 1227 - 1231
J. IMMUNOL., vol. 155, 1994, pages 4307
IMMUNOGENETICS, vol. 41, 1995, pages l78
INT. J. CANCER, vol. 100, 2002, pages 565 - 570
NAT. MED., vol. 4, 1998, pages 321 - 327
CANCER IMMUNOL. IMMUNOTHER, vol. 51, 2002, pages 271
SAMBROOK J.FRISCH E. F.MANIATIS T.: "Antibodies; A Laboratory Manual", 1989, COLD SPRING HARBER LABORATORY PRESS
"Current protocols in Molecular Biology", 1987, PUBLISH. JOHN WILEY AND SONS
"Peptide Synthesis", vol. 14, 1991, HIROKAWA SHOTEN, article "Development of Pharmaceutical Product sequential"
"The Proteins", vol. 2, 1976, ACADEMIC PRESS INC.
"peptide synthesis", 1975, MARUZEN CO., LTD.
DM. GLOVER: "Basics and Experiment of peptide synthesis", 1985, MARUZEN CO., LTD.
T. MANIATIS ET AL.: "Molecular Cloning", 1983, CSH LABORATORY
"Protective Groups in Organic Synthesis", 1990, JOHN WILEY & SONS, INC.
TETRAHEDRON LETTERS, vol. 37, no. 9, pages 1347 - 1350
DEVELOPMENT OF PHARMACEUTICAL PRODUCT SEQUENTIAL, vol. 14
NAT REV DRUG DISCOV., vol. 12, 2013, pages 130 - 146
NIKKEI MEDICAL CANCER REVIEW, vol. 9, 2014
NAT REV IMMUNOL., vol. 14, 2014, pages 559 - 69
CLIN. MICROBIOL. REV., vol. 7, 1994, pages 277 - 289
EUR J IMMUNOL., vol. 34, 2004, pages 3060 - 9
See also references of EP 3549957A4
CLIN CANCER RES, vol. 15, no. 17, 2009, pages 5323 - 37
CANCER RES, vol. 62, no. 22, 2002, pages 6438 - 6441
J IMMUNOL IMMUNOTHER, vol. 24, no. 3, 2001, pages 195 - 204
FRONT IMMUNOL, vol. 4, no. 172, 2013, pages 1 - 9
J IMMUNOL, vol. 166, no. 11, 2001, pages 6720 - 6727
J IMMUNOL, vol. 169, no. 2, 2002, pages 739 - 749
IMMUNITY, vol. 7, no. 3, 1997, pages 387 - 399
J IMMUNOL, vol. 176, no. 5, 2006, pages 2958 - 2968
PROC. NATL. ACAD. SCI. USA, vol. 90, no. 4, 1993, pages 1227 - 1231
J. IMMUNOL., vol. 155, 1994, pages 4307
IMMUNOGENETICS, vol. 41, 1995, pages l78
INT. J. CANCER, vol. 100, 2002, pages 565 - 570
NAT. MED., vol. 4, 1998, pages 321 - 327
CANCER IMMUNOL. IMMUNOTHER, vol. 51, 2002, pages 271
SAMBROOK J.FRISCH E. F.MANIATIS T.: "Antibodies; A Laboratory Manual", 1989, COLD SPRING HARBER LABORATORY PRESS
"Current protocols in Molecular Biology", 1987, PUBLISH. JOHN WILEY AND SONS
"Peptide Synthesis", vol. 14, 1991, HIROKAWA SHOTEN, article "Development of Pharmaceutical Product sequential"
"The Proteins", vol. 2, 1976, ACADEMIC PRESS INC.
"peptide synthesis", 1975, MARUZEN CO., LTD.
DM. GLOVER: "Basics and Experiment of peptide synthesis", 1985, MARUZEN CO., LTD.
T. MANIATIS ET AL.: "Molecular Cloning", 1983, CSH LABORATORY
"Protective Groups in Organic Synthesis", 1990, JOHN WILEY & SONS, INC.
TETRAHEDRON LETTERS, vol. 37, no. 9, pages 1347 - 1350
DEVELOPMENT OF PHARMACEUTICAL PRODUCT SEQUENTIAL, vol. 14
NAT REV DRUG DISCOV., vol. 12, 2013, pages 130 - 146
NIKKEI MEDICAL CANCER REVIEW, vol. 9, 2014
NAT REV IMMUNOL., vol. 14, 2014, pages 559 - 69
CLIN. MICROBIOL. REV., vol. 7, 1994, pages 277 - 289
EUR J IMMUNOL., vol. 34, 2004, pages 3060 - 9
See also references of EP 3549957A4
Attorney, Agent or Firm:
SAMEJIMA, Mutsumi et al. (JP)
Download PDF: